Why would anyone choose liraglutide over semaglutide?

FDA-approved

Liraglutide

GLP-1 receptor agonist · Subcutaneous injection · Sold as Saxenda, Victoza

The original once-daily GLP-1 (Saxenda for weight loss, Victoza for diabetes) — now largely superseded by weekly drugs but still relevant, including as a generic.

Last reviewed 2026-09-01 by the TopGLP1 Editorial Team

Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.

Key takeaways

Once-DAILY injection (unlike weekly semaglutide/tirzepatide).
Saxenda = weight loss; Victoza = diabetes.
More modest average weight loss (~5–8%).
Generic versions have begun to lower cost.

Liraglutide was one of the first GLP-1 medications used for weight loss. Unlike the newer weekly injections, it's taken once daily. It's sold as Saxenda for weight management and Victoza for type 2 diabetes.

Average weight loss is more modest than semaglutide or tirzepatide — around 5–8% in trials — and the daily injection is less convenient. As a result it's used less often now, but it remains an approved, well-understood option and has become available as a lower-cost generic in some markets.

How liraglutide works

Liraglutide is a GLP-1 receptor agonist like semaglutide, but with a shorter duration of action, which is why it's injected every day rather than weekly. It reduces appetite, slows gastric emptying, and improves blood-sugar control through the same core mechanism.

How well it works

~5–8% average weight loss over roughly a year.

In the SCALE weight-management trials, adults on 3.0 mg daily liraglutide lost an average of about 8% of body weight versus ~2–3% on placebo. Effective, but generally less than the newer weekly agents.

SCALE Obesity~8% mean weight loss over 56 weeks

LEADER (diabetes)Cardiovascular benefit in type 2 diabetes with heart disease

Dosing schedule

Saxenda escalates weekly to a 3.0 mg daily maintenance dose.

Week 10.6 mg once daily

Week 21.2 mg once daily

Week 31.8 mg once daily

Week 42.4 mg once daily

Week 5+3.0 mg once daily

Maintenance dose.

Victoza (diabetes) is typically dosed up to 1.8 mg daily.
Daily injection is the main practical drawback versus weekly options.

Side effects & safety

Common

• Nausea
• Diarrhea
• Constipation
• Vomiting
• Low blood sugar when combined with certain diabetes drugs

Serious (uncommon)

• Pancreatitis
• Gallbladder disease
• Thyroid C-cell tumor boxed warning

Side effects mirror other GLP-1 drugs and improve with slow escalation. The daily schedule means some people find side effects more constant.

What it costs

Branded (cash): $1,300+/month list for Saxenda; generic liraglutide is cheaper where available
Insurance: Coverage patterns resemble other GLP-1 drugs — diabetes indications are covered more readily than obesity.

Who it's for — and who should avoid it

Often a good fit

People who can't tolerate or access weekly agents
People who prefer or need a generic, lower-cost GLP-1

Not recommended for

People wanting maximum weight loss (weekly drugs outperform it)
Standard GLP-1 contraindications (thyroid tumor history, pregnancy)

Common questions

Cost and access, mostly. As a generic it can be cheaper, and it's a well-established option when weekly agents aren't available or tolerated. For pure weight-loss efficacy, the weekly drugs generally win.